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1. Introduction 
Cancer is the second most common cause of death in the Western world, after cardiovascular 
diseases (Johnson, 1991; 2001). Worldwide, an estimated cancer incidence of about 10 million 
was reported for the year 2009 (Jemal et al., 2010), and 1 out of every 3 persons is estimated to 
suffer from cancer by the age of 75 years (Johnson, 1991; 2001). It is also estimated that about 
7.9 million people world-wide will die from cancer this year (Jemal et al., 2010), accounting for 
nearly 12% of deaths worldwide (Jemal et al., 2010). In the United States alone, an estimated 
569,490 deaths from cancer are projected for the 2010 (Jemal et al., 2010). Recent published 
estimates of worldwide frequency of the 16 major cancers indicate that in developing countries 
with a high prevalence of infectious and nutritional diseases, cancer remains a major cause of 
death (Parkin, Laara and Muir, 1988). This may account partly for the current statistics 
whereby more than half the global incidence of cancer is from the so-called developing 
countries, since an estimated 70-80% of the global population resides in these areas (Parkin et 
al., 1998). The estimated annual incidence of cancer ranges from 48 to 225 per 100,000 in 
developing countries (Parkin et al., 1998). 
2. Oral cancer – Epidemiologic overview 
“Oral cancer” encompasses all malignancies originating in the oral cavity. Oral cancer ranks 
sixth in the overall incidence for the 10 most common cancer sites worldwide and third in 
the developing countries (Johnson, 2001)). There is also a marked disparity in geographic 
incidence between the “high” and “low” prevalence areas of the world, suggesting major 
geographic differences in risk factors (Johnson, 1991; 2001). Most of these factors have been 
identified through epidemiologic studies.  
For statistical purposes, oral cancer is often grouped together with cancers of the pharynx as 
“oropharyngeal” cancer (Daftary et al., 1992). In the Western world, oral cancer is relatively 
uncommon, and in the context of all malignant tumors, incidence in the United States and 
Great Britain ranges from 2 to 3% (Batsakis, 1979; Jemal et al., 2008).  Relative incidence of 
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up to 5% however has been reported for the United States (Batsakis, 1979), and higher rates 
have been reported for the so-called “high risk” areas of Europe with incidence equally 
varying with different socioeconomic groups within these areas (Johnson, 1991). 
Worldwide, it is estimated that about 300,000 people will be diagnosed with oral cancer in 
2010 (Jemal et al., 2010).  Of these, 126,000 will die from the disease (Jemal et al., 2010). In the 
United States alone, an estimated 35,000 new cases of oral cancer will be diagnosed in 2009 
with an estimated 7,500 resultant deaths (Jemal et al. 2008). In the Asian subcontinent of 
Bangladesh, India, Pakistan, and Sri Lanka, oral cancer is the most common malignancy, 
accounting for about one-third of all malignancies within the subcontinent (Daftary et al., 
1991; Jonson, 2001). About 100,000 new cases are estimated to occur annually in these 
regions that include Burma, Cambodia, Malaysia, Nepal, Singapore, Thailand, and Vietnam 
(Daftary et al., 1991).   
The paradox in the foregoing gloomy statistics is that, although the oral cavity and 
oropharynx are easily accessible to dentist and physicians for routine examinations and the 
biopsy of suspicious lesions that often present with outstanding features, early diagnosis has 
been painfully slow when compared with the enhanced early detection of breast, colon, 
prostate cancers, and melanoma (Mashberg A, 2000). As a result, the mortality rate from oral 
cancer for the past three and a half decades has remained high (over 50%) in spite of new 
treatment modalities. In contrast, there has been a considerable decrease in mortality rates 
for cancers of the breast, colon, prostate, and melanoma during the same period (Mashberg 
A, 2000). Examination of the colonic mucosa, which requires endoscopic examination for 
evaluation of colon cancer, reveals 36% of localized colon cancers among the United States 
population (Mashberg A, 2000). An identical percentage of localized oral/oropharyngeal 
cancers are diagnosed without endoscopy among the same population (Mashberg A, 2000). 
This paradox was eloquently summed up in a four decades-old publication highlighting  
“. . . the poor prognosis of a form of cancer, which presents exceptionally good opportunity 
for early treatment” (Banoczy and Csiba, 1976; Wright 1994).  
The impediment to early diagnosis of oral and oropharyngeal cancers, despite increased 
assiduousness on the part of dentists and oral physicians in their examination of patients at 
risk, stems from the persistence of archaic paradigms, and the lack of an easily available 
diagnostic adjunct. In order to increase the early detection of oral cancers, and by so doing 
increase the survival rates of oral cancer patients, there is therefore the need to identify 
diagnostic screening modalities that identify early oral malignant lesions with precision.  
About 95% of oral cancers are classified histologically as oral squamous cell carcinoma 
(OSCC; Mashberg, 2000; Johnson, 2001, Sargeran et al., 2008). The remaining 5% include 
such histologic variants as oral verrucous carcinoma, adenosquamous carcinoma, adenoid 
squamous cell carcinoma, mucoepidermoid carcinoma, and basaloid squamous cell 
carcinoma.  Mucoepidermoid carcinomas are malignancies of salivary gland origin and, 
within the oral cavity, arise from minor salivary glands, while adenosquamous 
carcinomas are currently believed to arise from the oral mucosa with subsequent 
glandular changes among the tumor cells.  Basaloid squamous cell carcinoma, a relatively 
newly recognized entity, is a rare histologic variant of OSCC with marked predilection for 
the base of tongue in addition to the supraglottic larynx and hypopharynx. Often 
included in the remainders are metastatic carcinomas from regional sites distant to the 
oral cavity. 
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3. Etiologic risk factors for oral cancer 
Oral cancer is a multifactorial disease. Exposure to one of three broad groups of 
carcinogenic stimuli, namely, chemical, physical, and viral, is known to induce cancer in 
genetically and systemically conditioned oral mucosa. Within the oral cavity, it appears that 
carcinomas are caused predominantly by chemical carcinogens, although evidence 
implicating viral and physical stimuli in the development of some oral cancers continues to 
mount (Syrjanen, 2005; Reddout et al., 2007). The pathogenesis of oral cancer is equally 
complex, and exposure to carcinogens does not inevitably result in the development of oral 
cancer. This is because a number of familial, dietary, hormonal, and sex-related factors are 
known to modulate neoplastic processes generally. Tobacco and alcohol have emerged as 
the most important culprits contributing to the etiology of oral cancers. Other factors 
frequently cited are ultraviolet light, nutritional and dietary factors, precancerous lesions, 
immunosuppression, genetic, and dental factors. 
3.1 Tobacco and tobacco products 
An association between the use of tobacco and oral cancer can be traced to the early 18th 
century, when lip cancer was observed with some frequency in tobacco users (Sawyer and 
Wood, 1992). The strong association of cancers of the oral cavity and oropharynx with 
tobacco use is well established (Johnson, 2001). Epidemiological studies show that the risk of 
developing oral cancer is five to nine times greater for smokers than for nonsmokers, and 
this risk may increase to as much as 17 times for heavy smokers of 80 or more cigarettes per 
day (Neville and Day, 2002). Approximately 80 percent of oral cancer patients are smokers, 
and this is two to three times greater than that of the general population (Silverman and 
Griffith, 1972; Blot et al., 1988; Mashberg et al., 1993; Jovanovic et al., 1993; Andre et al., 1995, 
Lewin et al., 1998). In addition, treated oral cancer patients who continue to smoke have a 
two- to six- times greater risk of developing a second malignancy of the upper aerodigestive 
tract than those who stop smoking (Silverman and Griffith, 1972; Silverman and Shillitoes, 
1998).  
Oral smokeless tobacco (snuff and chewing tobacco) have also been associated with an 
increased risk for oral cancer (Brown et al., 1965). In one study of women in the southern 
United States, chronic users of snuff were estimated to have a four times greater risk of 
developing oral cancer (Winn et al., 1981, Johnson, 2001). In addition, a significant number 
of oral cancers in smokeless tobacco users develop at the site of tobacco placement. 
However, the use of smokeless tobacco appears to be associated with a much lower cancer 
risk than that associated with smoked tobacco. For example, although the state of West 
Virginia has the highest consumption of chewing tobacco in the United States, the incidence 
of oral cancer in West Virginia is below the U.S. national average (Bouquot and Meckestroth, 
1998). Recent studies from Scandinavia have suggested that the use of Swedish snuff (which 
is nonfermented and has lower nitrosamine levels) is not associated with an increased risk 
for oral cancer (Johnson, 2001; Neville, 2002).  
The habit of oral smokeless tobacco use is evolving as “fashionable” amongst the youth in 
many Western countries, and may partly account for spikes in the rate of oral cancers and 
potentially malignant lesions observed in this age group in recent decades (Johnson, 1991). 
The importance of teenage use of smokeless tobacco lies in the considerable length of time 
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that the oral mucosa of teenagers indulging in this habit are bathed in high concentrations of 
numerous carcinogens contained in smokeless tobacco (Sawyer and Wood, 1992). In 
addition to carcinogens usually associated with smoking, smokeless tobacco contains 
210polonium (originating from phosphate fertilizers used to grow tobacco), 226radium, and 
210lead (Main and Lacavalier, 1988). Furthermore, tobacco-specific nitrosamines present in 
smokeless tobacco, and readily extracted in saliva and further enhanced in alkaline 
environments, often are of higher concentrations than in cigarette smoke (Sawyer and 
Wood, 1992).  
In India and Southeast Asia, the chronic use of betel quid (paan) in the mouth has been 
strongly associated with an increased risk for oral cancer (Murti et al., 1985; Murti et al., 
1995). The quid typically consists of a betel leaf that is wrapped around a mixture of areca 
nut and slaked lime, usually with tobacco and sometimes with sweeteners and condiments. 
The slaked lime results in the release of an alkaloid from the areca nut, which produces a 
feeling of euphoria and well-being in the user. Betel quid chewing often results in a 
progressive, scarring precancerous condition of the mouth known as oral submucous 
fibrosis. In India, one study showed a malignant transformation rate of 7.6 percent for oral 
submucous fibrosis (Murti et al., 1985).  
Marijuana use is also considered to be a potential risk factor and may be partly responsible 
for the rise in oral cancers seen among young adults (Zhang et al., 1999; Silverman, 2001; 
Schantz and Yu, 2002). Marijuana smoke contains known carcinogens such as benzopyrene 
and benzanthracene (aromatic hydrocarbons), and the concentration of these carcinogens is 
postulated to be considerably higher than that in cigarette smoke (Sawyer and wood, 1992). 
However, further epidemiological studies are necessary to confirm the purported association 
of marijuana and oral cancer, particularly in younger patients.  
3.2 Alcohol 
The relationship between alcohol, particularly hard liquor, and squamous cell carcinoma 
has been recognized for a long time (Wynder, 1971), and has been identified as a major risk 
factor for cancers of the upper aerodigestive tract (Neville and Day, 2002). What presented 
as a significant challenge, until recently, was the assessment of the independent role of 
alcohol in oral cancers due to the difficulty in separating the effects of heavy alcohol 
consumption from those of smoking and other risk factors, including nutritional (Kato and 
Nomura, 1994). Most heavy consumers of alcohol beverages also are heavy smokers.  
In studies controlled for smoking, moderate-to-heavy drinkers have been shown to have a 
three- to nine- times greater risk of developing oral cancer (Blot et al., 1988; Mashberg et 
al., 1993; Jovanovic et al., 1993; Andre et al., 1995; Lewin et al., 1998). One study from 
France showed that heavy drinkers, consuming more than 100 grams of alcohol per day (a 
typical serving of beer, wine, or liquor approximates 10 to 15 grams of alcohol), had a 30 
times greater risk of developing oral and oropharyngeal cancer (Andre et al., 1995). Thus, 
it would appear that smoking is not a necessary prerequisite for alcohol induced cancers. 
Of greater significance however is the synergistic effect of alcohol and smoking; some 
subsets of patients who are both heavy smokers and heavy drinkers can have over one 
hundred times greater risk for developing a malignancy (Blot et al., 1988; Andre et al., 
1995).  
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While the mechanism of alcohol-induced carcinogenesis remains unclear, it is apparent that 
alcohol acts primarily as a co-carcinogen or promoter. Carcinogenesis also may be related to 
nutritional deficiencies associated with alcoholism. Systemically, alcohol may lead to 
impaired absorption of nutrients and vitamins. It has been suggested that alcohol acts as a 
solvent facilitating the entry of carcinogens into exposed cells (Sawyer and Wood, 1992). In 
addition to creating a nutritional deficiency state (Harris et al., 1997; Johnson, 2001), alcohol 
may alter epithelial cell metabolism, or suppress immunity (Cotran, Kumar and Robbins, 
1989). There is some evidence that carcinogenic contaminants rather than ethanol may be 
responsible for the increased incidence of alcohol-associated cancers (Bennie, 1976). 
3.3 Human Papilloma Viruses (HPV) 
The role of HPV as an etiologic agent in cancer was first recognized in the uterine cervix 
(where it is present in about 99.7% of cases), and the prognostic significance of HPV-
associated cervical cancer is now well established (Clifford, Boyle and Franceschi S, 2003; 
Reddout, 2007). HPV-16 and -18 are the major high-risk types and predominate in invasive 
anogenital cancers (Clifford et al., 2003; Reddout, 2007). On the other hand there is as yet no 
clear evidence to support a causative role for HPV in OSCCs, and any potential pathogenic 
mechanism of HPV-associated OSCCs is still confounding. At best, an association between 
HPV infection and oral cancer is accepted by most investigators in this field.  
In oral lesions, HPV-16 is by far the most common subtype associated with OSCCs and oral 
premalignant lesions (OPL) exhibiting epithelial dysplasias (Reddout, 2007). HPV-16 DNA 
has been identified in primary tumors of the tonsil, hypopharynx, oral cavity, tongue, and 
nasopharynx, as well as in cell-lines derived from these regions (Syrjanen, 2005; Reddout, 
2007). Metastatic lymph nodes lesions have also been shown to contain DNA of the same 
HPV type as in the primary tumor in 76% of the cases, supporting the involvement of HPV 
in the development of OSCC (Clifford et al., 2003; Syrjanen, 2005; Reddout, 2007).  
The prevalence of HPV-16 in OSCC is now considered to be as high as 50% if not more, 
making it likely that every alternate OSCC patient is HPV-16 positive (Syrjanen, 2005; 
Reddout, 2007). The association is strongest in the oropharynx, most notably in the tonsil 
and base of tongue, which present more frequent basaloid histomorphology and less 
frequent p53 mutations (Clifford et al., 2003). In addition, HPV-16 has been detected in 
extremely low copy numbers (compared to copy numbers in OSCC and dysplastic OPLs) in 
some human “normal” oral mucosa (NOM), suggesting that a threshold viral DNA copy 
number is required for the role of oncogenic HPVs in oral carcinogenesis. HPV-18 is far less 
commonly associated with oral cancers, and has been found in up to just 14 percent of cases 
(Kang and Park, 2001). 
It is now established that the products of two early genomic regions of high-risk HPVs, E6 
and E7, are capable of forming specific complexes with vital cell cycle regulators (Kang and 
Park, 2001). For example, E6 binds to p53 to induce p53 degradation, while E7 interacts with 
pRb resulting in blockage of the downstream activities of pRb (Kang and Park, 2001). Both 
p53 and pRb are oncosuppressors, and the overall outcome of their functional dysregulation 
is an uncontrolled DNA replication and impairment of apoptosis. The combined effects of 
apoptotic impairment and uncontrolled DNA replication are increased tendency towards 
cellular transformation and tumorigenesis. 
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3.4 Nutritional factors 
The role of metabolic and dietary deficiencies in the etiology of OSCC was long suspected 
before concrete evidence began to emerge. Peterson (1919) and Kelly (1919) independently 
described the symptom complex of chronic dysphagia, mucosal atrophy of the 
hypopharynx, and chronic anemia in middle-aged women who also had cricoid carcinomas. 
The term sideropenic dysphagia was introduced, and used to describe the disease complex 
now referred to as Paterson-Kelly (or Plummer-Vinson; P-V) syndrome. P-K syndrome is 
marked by diminished iron stores and the absence of stainable bone marrow iron. Other 
components of the syndrome include riboflavin and other vitamin deficiencies. Subsequent 
studies by Ahlbom (1936) confirmed not only the importance of P-K syndrome in the 
development of pharyngeal cancers, but also showed that this applied to the buccal mucosa, 
tongue, and all levels of the esophagus. 
There is a high incidence of oral cancer in parts of the world where iron deficiency is endemic 
(Prime, MacDonald and Rennie, 1982). Iron metabolism is essential for the overall integrity 
and health of epithelia of the digestive tract, and its importance may lie in its contribution to 
normal enzymes. Rennie and MacDonald (1982), and Rennie, MacDonald and Dagg (1982) 
demonstrated quantitative histologic changes in the oral epithelium in human iron deficiency 
anemia and in experimental iron deficiency in hamsters. The authors noted that the oral 
epithelium in iron deficiency is atrophic with reduced maturation compartment, but an 
increased keratinized compartment (Rennie et al., 1982). Subsequent cell kinetic studies by 
Rennie and MacDonald (1984) showed increased cell proliferation, indicating that, in spite of 
the atrophy, epithelial turnover is rapid. This observation suggested a possible increase in 
susceptibility to chemical carcinogens due to both an increase in the population of potentially 
vulnerable dividing cells and to a more permeable epithelium. 
Increased cancer risks also are attributable to dietary factors, notably low intake of fruits and 
vegetables (Winn et al., 1984; Winn, 1995). Increased consumption of fruits and vegetables 
were said to be protective against oral cancer when controlled for demographic 
characteristics, tobacco and alcohol use, relative weight, and the intake of other food items 
(Winn et al., 1984). The reduction of risk is seen to be consistent with the hypothesis that 
Vitamin C and/or Vitamin A and ß-carotene intake is associated with a reduced risk of oral 
and pharyngeal cancers (Ibrahim, Jafarey and Zuberi, 1977). Interestingly, intervention trial 
studies with ß-carotene and Vitamin A in patients with oral precancer have been shown to 
result in substantial regression of the lesions (Stich et al., 1988a, 1988b). 
Degenerative changes occur in riboflavin deficiency, a frequent finding in alcoholics. This 
may partly explain the relationship between alcoholism and oral cancer (Wynder and Klien, 
1965). It also may be that alcohol increases the risk of oral cancer by lowering nutritional 
status via a substitution of non-nutritive calories for vitamins, minerals, and other elements; 
alternatively, that poor nutrition allows the deleterious effects of alcohol to be manifested. 
3.5 Impaired immunity 
Generally, patients with malignancies have some degree of immunosuppression that tends 
to worsen with the progression of their malignancy. Immunosuppression appears to 
predispose some individuals to an increased risk for oral cancer. Carcinomas of the lip have 
been reported in a number of kidney transplant patients receiving immunosuppressive 
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medications, and oral carcinomas have been documented in young AIDS patients (van 
Zuuren, de Visscher JGAM, Bouwes Bavinck JN, 1988; Flaitz et. al., 1995; de Visscher, 
Bouwes Bavinck JN and van der Waal, 1997; Flaitz and Silverman, 1998). It is however still 
debated as to whether immunosuppression in malignant disease represents an effect or a 
cause of the malignancy. Some studies have suggested that immunosuppressive states may 
represent the effect rather than the cause of cancer (Johnson, 1991), while others have 
suggested that OSCC, despite its local manifestations, is most likely a “regional” disease 
process that becomes “clinically significant” only when the patient’s immunologic status is 
altered (Mashberg and Samit, 1989). 
It would appear however that a factor such as advanced age, which diminishes immune 
competence and immune cellular surveillance, increases the risks of oral cancer. Overt 
immune suppression induced by chemicals or drugs, or caused by specific viral infections 
such as the human immunodeficiency virus (HIV), or Epstein Barr virus (EBV), increases the 
risk of oral cancers. Barr et al. (1989); Bradford et al. (1990) variously suggested that HPV 
may play an etiologic role in squamous cell carcinoma in renal allograft recipients. 
3.6 Oral Premalignant Lesions 
Oral premalignant lesions (OPLs) are lesions, often presenting on the oral mucosa, which 
possess a higher than normal propensity for transformation to OSCC with time if untreated. 
The current model for oral carcinogenesis postulates a step-wise transformation from 
normal to pre-malignant to invasive carcinoma phenotype.  Histologically, the transition 
process involves progression from benign epithelial hyperplasia to various degrees of 
epithelial dysplasia (mild, moderate, severe) to carcinoma in situ, and finally to invasive 
OSCC. With respect to transition to OSCC, oral leukoplakia, oral erythroplakia, and 
speckled leukoplakia are the most notable and most studied OPLs (Figure 1.1). The 
transition rate of oral leukoplakia to OSCC is estimated at between 4 and 18%, while that of 
OLP is to be between 1 and 4%.  
Although erythroplakia is not nearly as common as leukoplakia, it is much more likely to 
show dysplasia or carcinoma histologically. In a study by Shafer and Waldron (1975) of 
biopsies of erythroplakic lesions from 65 patients, all cases showed some degree of epithelial 
dysplasia: 51 percent showed invasive squamous cell carcinoma; 40 percent were carcinoma 
in situ or severe epithelial dysplasia; and the remaining 9 percent demonstrated mild-to-
moderate dysplasia (Shafer and Waldron, 1975). Thus, true clinical erythroplakia is a much 
more worrisome lesion than leukoplakia (Mashberg and Samit, 1995). Likewise, in a mixed 
leukoplakia-erythroplakia (erythroleukoplakia), the erythroplakic (red component) is more 
likely to demonstrate dysplastic changes than is the white component, making it imperative 
that that biopsy sites be selected to ensure that the specimen incorporates the red 
component. In addition, a number of studies have suggested that oral lichen planus (OLP), 
especially the erosive form, may be associated with an increased cancer risk, although other 
investigators have questioned the strength of this association (Silverman et al., 1991; Barnard 
et al., 1993; Eisenberg, 2000).  
4. Site distribution in oral cancer 
Symptomatic lesions present with symptoms and signs such as intraoral pain and/or 
dysfunction, extraoral swelling, and cervical lymphadenopathy. These signs and symptoms 
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alert the clinician to the need to evaluate the oral cavity for obvious primary lesions. Site 
distribution in OSCC is usually described in relation to the symptomatic lesions, which are 
often amenable to classification under the “T” category of the TNM classification of 
malignant tumors (Neville and Day, 2002). The TNM classification allows for the clinical 
staging of oral malignant tumors on the basis of the size of the primary tumor, T, the 
absence or presence of corresponding regional node spread, and the absence or presence of 
distant site/organ metastases (Neville and Day, 2002). In OSCC, T1 lesions are 2cm or less in 
greatest dimension; T2 lesions are more than 2cm but not more than 4cm in greatest 
dimension; T3 lesions are more than 4cm in greatest dimension, and T4 lesions are those that 
have invaded adjacent contiguous structures such as the cortical bone, inferior alveolar 
nerve, deep extrinsic muscles of the tongue, maxillary sinus, or salivary glands regardless of 
their apparent visual dimension (Neville and Day, 2002).  
Early asymptomatic lesions are relatively small (T1) and, not infrequently, elude clinical 
diagnosis by conventional systems (Mashberg and Meyers, 1976; Neville and Day, 2002). 
These early asymptomatic lesions, often presenting as erythroplastic lesions, were studied 
by Mashberg and Meyers (1976) who consequently provided guidance toward enhanced 
accurate designation of sites of origin of these early asymptomatic lesions (Mashberg and 
Meyers, 1976). In this respect, the authors further concluded thus: “The described locations 
in the literature may be points of termination or extension of the lesion rather than sites of 
origin, e.g., a symptomatic lesion (T2 or T3) in the floor of mouth may have extended to and 
invaded the alveolus; hence, based on clinical and x-ray evidence, it may have been reported 
as a gingival or alveolar lesion” (Mashberg and Meyers (1976). 
There are geographic variations in the frequency of sites of involvement, probably related 
to such risk factors as occupation and lifestyle, oral habits, and certain socio-cultural 
practices, such as the mode of tobacco use (Paymaster, 1962; Brown et al., 1965). For 
example, presentation of intraoral cancers among the population of the high risk areas of 
Southeast Asia and the Southeast United States is slightly different.  Consistent with the 
role of the risk factors alluded to above the most prone sites in the high risk areas of 
Southeast Asia are the buccal, retromloar, and commissural mucosa (Paymaster, 1962; 
Brown et al., 1965). 
4.1 The lip 
The World Health Organization (WHO) revision of the International Classification of 
Diseases (ICD) defines cancer of the lips as malignant lesions of the vermilion area of the 
upper and lower lips (Daftary et al., 1992). Cancers in these areas are not considered 
intraoral cancers (Daftary et al., 1992). Over 90% of lip cancers involve the lower lip 
(Neville and Day, 2002). Lip lesions are easily detectable partly because the lip is the most 
visible structure of the oral cavity complex. Lip squamous cell carcinomas usually arise in 
actinic cheilosis, a premalignant condition, which is a “cousin” to actinic keratosis of the 
skin. Actinic cheilosis is characterized by atrophy of the vermilion border, clinically 
visible as dry, scaly changes. Ulcerated foci alternating with partial healing may appear as 
the lesion progresses. Not infrequently, patients mistake these recurring ulcerated lesions 
for "fever blisters." Subsequently, the evolving cancer slowly becomes a crusted, non-
tender, indurated ulcer or mass (Neville et al., 2009; Silverman, Dillon and Fischbein, 
1998).  
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In Romania, Hungary, Yugoslavia, and parts of Canada and the United States, the vermilion 
area of the lips are the commonest sites of oral cancer (Johnson, 1991; 2001), and it has been 
reported that about half of all cases of oral cancer in the Nordic countries occur on the lips 
(Ringertz, 1971). The lateral aspect of the lower lip is more frequently involved than the 
mid-portion (Daftary et al., 1992). Race and ethnic variations in the incidence of lip cancer 
occur worldwide. Among most white population, the lip constitutes the most common site 
for oral cancer (Spitzer et al., 1975; Johnson, 1991; 2001). Considerable agreement over the 
association between lip cancer and occupation exists; the disease being common amongst 
white males who engage in outdoor occupations, such as farming and fishing, which expose 
them excessive sunlight (Spitzer et al., 1975; Johnson, 1991; 2001). On the other hand, lip 
cancer is relatively rare in black males, and females of both white and black races (Bernia, 
1948; Spitzer et al., 1975; Johnson, 1991; 2001). 
In a 1984 study reported by Douglass and Gammon there was variation in the incidence of 
lip cancer between the male non-Maori (1.7/ 100,000) and the Maori (0.2/100,000) 
population of New Zealand (Douglass and Gammon, 1984). The authors similarly 
highlighted ethnic differences in the incidence of lip cancer in Israel where males born in 
Israel had a higher rate of lip cancer (3.5/100,000) than male immigrants from 
Europe/America (2.9/100,000), or Africa/Asia (0.8/100,000). 
4.2 The tongue and floor of mouth 
The tongue is the most common site for intraoral carcinoma and accounts for about 40 
percent of all cases in the oral cavity proper, with tumors occurring on the posterior lateral 
border and ventral surfaces of the tongue (Neville and Day, 2002). The incidence of floor-of-
mouth squamous cell carcinoma closely approximates that of the tongue (Neville and Day, 
2002). In the black population however the floor of mouth distinctly is the most common site 
for OSCC (Batsakis, 1979). Thus, anatomically, the lateral tongue and floor of mouth 
(extending to the lateral soft palate and tonsillar area) combine to form a horseshoe-shaped 
region of the oral mucosa, which is at greatest risk for cancer development (Neville and Day, 
2002). Two major factors may explain the high-risk status of this composite region: first, 
carcinogens in saliva pool at the floor of the mouth with the tongue providing a lid; second, 
this complex is covered by a thinner, non-keratinized mucosa, thus providing limited barrier 
to carcinogen ingress (Jovanovic et al., 1993).  
4.3 Buccal mucosa 
The mucosal surface of the cheek extends from upper to lower vestibular sulci, where the 
mucosa reflects itself to cover the upper and lower alveolar ridges. The buccal mucosa also 
forms the commissure of the lip and covers the ramus of the mandible. A number of buccal 
squamous cell carcinomas originate in the commisural areas before spreading posteriorly to 
involve the mucosa along the occlusal plane of the teeth, or at the retromolar area (Batsakis, 
1979). It has been suggested that, because commissural cancers have better prognoses than 
buccal mucosa cancers, the former ought to be separated from the latter for purposes of site 
designation (Daftary et al., 1992). However, this suggestion appears not to have gained wide 
acceptance. Buccal cancers usually arise on the mucosa lying against the wisdom teeth, and 
correspond to the common site of placement of tobacco-containing quid. The lesion then 
grows to obscures the site of origin (Singh and von Essen, 1966; Batsakis, 1979; Daftary et al., 
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1992). Results of some studies indicate a consistent increase in the incidence of buccal 
cancers in relation to smokeless tobacco use (Brown et al., 1965; Winn et al., 1981). These 
findings underscore the importance of local etiologic factors in the site distribution of 
intraoral cancers. 
4.4 The gingiva and alveolar ridge 
Cancer of the gingivae and alveolar ridge are usually grouped together. Squamous cell 
carcinomas of the gingival and alveolar ridge generally are less common than those of the 
lip, tongue, and floor of mouth (McCarthy and Shklar, 1964). Similar to buccal and 
commissural cancers, Daftary et al., (1992) suggested that lesions of the gingivae and 
alveolar ridge be separated because of differences in prognosis. The incidence of carcinoma 
of the gingivae and alveolar ridge among the rural women of the Southeast United States is 
relatively high (Rosenfield and Callaway, 1963). The reported incidence of cancer of the 
gingival and alveolar ridge in three Indian populations ranged from 0.6/100,000 to 
1.4/100,000 per annum among women (Daftary et al., 1992). Carcinoma of the gingivae 
generally arises in the premolar and molar regions and more frequently, on the lower than 
on the upper arch (Cady and Catlin, 1969). These correspond to the sites of retention of 
tobacco quid in those who practice the habit. 
4.5 The palate 
Squamous cell carcinomas of the palate are in the Western countries and the United States 
(Daftary et al., (1992). Again, incidence significantly reflects different habits. In India, for 
example where the habit of “reverse smoking” is prevalent among the population, the 
relative frequency of squamous cell carcinoma of the palate is high (Gupta et al., 1980; 
Daftary et al., 1992). The habit of reverse smoking is exemplified by the practice of placing 
the glowing end of a local form of cigar called “chuttas” inside the mouth. In areas where 
reverse smoking is practiced palatal cancer comprise 38 to 48 percent of all oral cancers 
(Gupta et al., 1980; Daftary et al., (1992). Lesions of the hard palate may arise in the midline 
or to one side close to the palatal gingivae (Batsakis, 1979). 
Primary squamous cell carcinomas arising in the soft palate are uncommon, accounting for 2 
percent of overall oral cancer in reverse-smoking areas (Ramulu et al., 1973), but only 0.4 
percent in non-reverse smoking areas (Wahi et al., 1965). However, reports of later studies 
by Mashberg and Meyers (1976) indicated a greater frequency of lesions primarily arising 
from the soft palate than is ordinarily documented with the “late” symptomatic lesions. On 
analyzing the site distribution of 222 cases of early asymptomatic OSCCs, the authors found 
that 64 of these (28.8 percent) occurred in the “soft palate complex” comprising the soft 
palate, anterior pillar of fauces, and retromolar trigone. Thus, some of the lesions designated 
hard palate lesions at the time of diagnosis may have earlier arisen from the soft palate 
before spreading to the hard palate at a late symptomatic stage. 
5. Diagnosis and management of oral cancer 
Early diagnosis of oral cancer has emerged as a priority public health objective whereby oral 
health professional play leading role (Neville and Day, 2002). It is presumed that early 
diagnosis of cancer should lead to less damage from interventional treatment and to a better 
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prognosis. Because most individual are seen more commonly by primary care physicians and 
general dentists than by specialists, it is imperative for these clinicians to perform screening 
examinations to identify potential oral and pharyngeal cancers. In addition to the need for 
improved early detection by clinicians, it is also important that the patient and general public 
are knowledgeable about the disease (Yellowitz and Goodman, 1995; CDC, 1998). Delays in 
identification and recognition of suspicious lesions contribute to advanced stage at diagnosis 
and lower survival statistics (Shafer, 1975; Hollows, McAndrew and Perini, 2000).  
5.1 Diagnosis of oral cancer 
A distinction has been made in the early detection of oral cancers between “screening” (test 
aimed at evaluating presence of the disease in asymptomatic individuals) and “detection of 
cases” (applying specific procedure to patients with a suspicious lesion; Lestón and Dios, 
2010). Nevertheless, conventional visual examination accompanied by palpation of 
suspicious lesions remains the gold standard screening methodology for oral precancer and 
cancer, while biopsy and histopathologic examination remains the universal diagnostic 
confirmatory test of choice (Lestón and Dios, 2010). Thus, in spite of the availability of 
several techniques that have been advocated as aids to oral cancer diagnosis (summarized in 
Table; adapted from Lestón and Dios, 2010) suspected malignant lesions must be biopsied in 
order to establish a definitive diagnosis.  
 
Toluidine blue  
Light-based detection systems  
Chemiluminescence (ViziLite Plus®; Microlux/DL®) 
Tissue fluorescence imaging (VELscope®)  
Tissue fluorescence spectroscopy 
Cytology or brush biopsy (OralCDx®)  
Specific  analysis (, SCCAA, IAP, CYFRA, , and others)   
Specific  analysis (, , , CYFRA 21-1, TPS, IL-1B, DUSP 1, HA3, , , SAT, miRNA, and others)   
Imaging (DPT, CT, CBCT, MRI)   
Table 1. Some techniques advocated for the clinical diagnosis of OSCC supplementing 
conventional oral examination, and histopathologic examination of suspicious lesions 
(adapted from Lestón and Dios, 2010). 
In turn, the accurate diagnosis of potentially malignant and malignant oral lesions depends 
on the quality of the biopsy, selection of appropriate technique (e.g. incisional versus 
excisional), the applicability of the adequate clinical information, and competent 
interpretation of the biopsy results. Oral biopsy specimens can be affected by a number of 
artifacts resulting from crushing, fulguration, injection, or incorrect fixation and freezing 
(Trullenque-Eriksson et al., 2009). Results of cytologic examination of specimens obtained 
from non-invasive procedures such as brush biopsies or comparable techniques must not 
constitute the sole basis for a diagnosis of malignancy (or the absence) leading to definitive 
treatments. This is because these non-invasive techniques often are fraught with several 
pitfalls accounting for high rates of false-negative and false-positive results. 
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5.2 Management of oral cancer patients 
While an exhaustive discussion on the management of oral cancer and precancerous lesions 
is not intended in this review, it is generally recommended that leukoplakias exhibiting 
degrees of epithelial dysplasia equal to, or worse than, moderate epithelial dysplasia be 
removed completely when possible (Epstein et al., 2007). On the other hand, the 
management guideline for mild dysplastic lesions is far less standardized with varied 
schools of thought ranging from those advocating a “wait-and-see” approach to those 
advocating total removal of all dysplastic lesions regardless of the degree of epithelial 
dysplasia. In addition, management decisions for mild epithelial dysplasia appear to be 
influenced by the size, location, and apparent etiologic factor accounting for the lesion. 
Some early dysplastic lesions where an etiologic agent (e.g. smoking) is identified have been 
known to regress and may reverse to normal on elimination of the etiologic factor 
responsible.  
Patients with invasive oral cancer are best managed by a coordinated, multidisciplinary 
team of health care professionals, which may include a head and neck surgeon, oral and 
maxillofacial pathologist, general pathologist, radiation oncologist, neuroradiologist, 
reconstructive surgeon, medical oncologist, general dentist, oral and maxillofacial surgeon, 
maxillofacial prosthodontist, dental hygienist, nurse specialist, speech pathologist, 
nutritionist, and tobacco cessation counselor (Ord and Blanchaert, 2001).  
Up to 15 percent of individuals with oral cancer harbor a second primary, making a 
complete head and neck examination that includes the larynx imperative (Lippman and 
Hong, 1989). Endoscopy of the larynx, esophagus, trachea, and lungs to rule out the 
possibility of other lesions in the high-risk patient is now performed routinely. For patients 
who present with a neck mass but no obvious primary site (or if the neck mass is more 
amenable to biopsy than the primary tumor), a fine needle aspiration remains the diagnostic 
method of choice rather than an open biopsy, because open biopsy has been reported to be 
related to a lower survival rate when not accompanied by a simultaneous neck dissection 
(Lefebvre et al., 1990; Kleid and Millar, 1993).  
Also, imaging studies are now routines during the evaluation of primary oral tumors and 
neck disease. Both contrast-enhanced computed tomographic (CT) scans and magnetic 
resonance imaging (MRI) may be utilized in determining the extent of the primary tumor, 
invasion, regional node status, and distant metastasis, thereby providing important staging 
information (Som, Curtin and Mancuso, 1999, Robbins, 1999). Positron emission tomography 
(PET) scans are also becoming an increasingly popular tool for the identification of primary, 
recurrent, and metastatic diseases.  
The treatment options for primary OSCCs are variable and depend on the size and location 
of the tumor, lymph node status, presence or absence of distant metastases, the patient’s 
ability to tolerate treatment, and the patient’s desires. Surgery and/or radiation therapy 
remain the gold standards for treatment of cancers of the lip and oral cavity. Oropharyngeal 
cancer may be treated with surgery and/or radiation therapy for early-stage disease. For 
advanced-stage disease, surgery with adjuvant radiation therapy may be indicated, 
although recent evidence suggests that the addition of chemotherapy to radiation therapy 
may provide a survival advantage over radiation therapy alone in this population 
(Forastiere, 1998; Calais et al., 1999). It is important to take into account disease status and 
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prevalence of occult disease in the neck when evaluating primary cancers of the lip, oral 
cavity, and oropharynx (Robbins et al., 2001). Regardless of the treatment modality used, 
many patients will require consideration of problems related to airway protection, enteral 
feedings, xerostomia, mucositis, dysphagia, and voice change.  
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diagnosis remains slow compared to the enhanced detection of cancers of the breast, colon, prostate, and
melanoma. As a result, the mortality rate from oral cancer for the past four decades has remained high at over
50% in spite of advances in treatment modalities. This contrasts with considerable decrease in mortality rates
for cancers of the breast, colon, prostate, and melanoma during the same period. This book attempts to
provide a reference-friendly update on the etiologic/risk factors, current clinical diagnostic tools, management
philosophies, molecular biomarkers, and progression indicators of oral cancer.
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